安发国际
新闻快车

抗生素耐药来袭:不要等到疾病无药可治才来治

来源:www.cnzxzy.com | 作者:甘诺宝力 | 发布时间:2017-11-09 | 点击量:

“我们一定要做得更好。我们不能,也不应该低估抗微生物药物耐药性这一威胁的规模。我们将很快面对数十年来能轻易治好的常见感染和小病会致命的新现代时期。”

 

——谭德塞博士

世界卫生组织总干事

安发国际 www.cnzxzy.com

 

抗微生物药物耐药性正快速成为世界上最大的健康风险之一。由于抗微生物药物耐药性的扩散,许多上个世纪的医疗突破将会失去效力。之前能治愈的传染病也会变得无法治疗,有在全世界传播的风险。

 

安发国际官网2015年4月获悉,世卫组织发布了《世界各地国家情况分析:应对抗微生物耐药性》报告,展现了许多政府正在积极采取措施应对这一问题,以及世卫组织六大地区存在重大差距。

 

甘诺宝力

 

继续阅读了解造成抗微生物药物耐药性的主要原因,以及世卫组织如何帮助领导全球应对:

 

1

抗微生物药物耐药性是什么

抗微生物药物耐药性就是微生物(像细菌、病毒、寄生虫和真菌)阻止抗微生物药物(如抗生素、抗病毒药物、抗疟药或抗真菌药)对其产生作用的能力。这样一来,标准的治疗方法就会失去效力,感染持续存在并会传播给他人。

 

2

耐药性属于全球性问题

过去几年中,抗微生物药物的使用和误用使耐药微生物的数量和种类增加。其后果是,多种传染病可能会再次变得不可控制。随着全球贸易和旅行的增加,耐药微生物可能会快速蔓延到世界每一角落。

 

安发国际官网

 

3

导致耐药性的原因是什么

耐药性是一种自然进化现象。当微生物接触到抗微生物药物时,敏感的生物被杀死,对药物有抗性的生物则生存下来。这些生物繁殖并将其抗性传给后代,在有些情况下,还会传给其它微生物。

 

4

用药不当加剧耐药性

抗微生物药物使用不当加快耐药性的发展。抗微生物药物的过度使用和错误使用都会导致耐药。确保病人知道使用正确抗生素的正确剂量要求开药者、药剂师、配药者、医药企业、公众和病人,以及政策制定者的行动。

 

5

研发抗击耐药性新工具需要新投资

现有的抗生素和抗寄生虫药物,以及更小范围内的抗病毒药物正在失去疗效。同时,用于开发新的抗微生物药物的投资不足。同样,在开展新的研究获得发现需要治疗的感染及耐药微生物的新诊断制剂以及预防和控制感染的新疫苗方面力度不够。如果这种趋势持续下去,与耐药微生物作斗争的工具库将会很快耗尽。

 

安发国际

 

世卫组织呼吁各利益攸关方与耐药性作斗争。耐药性威胁正在加大,有必要紧急行动起来,而我们每个人都必须发挥作用。在2015年5月召开的第六十八届世界卫生大会上,成员国通过了一份遏制抗微生物药物耐药性全球行动计划。甘诺宝力健康您的身体,从修复您的细胞、激活细胞、再生细胞开始!

 

 

 

 

Antimicrobial Resistance: When Diseases Become Untreatable 

 

“We have to do better. We cannot and must not underestimate the scale of this threat. We could soon face a new modern era where common infections and minor ailments - all of which we’ve been treating with relative ease for decades -become lethal.” – Director-General Dr. Tedros

 

Antimicrobial Resistance (AMR) is quickly becoming one of the world’s greatest health risks. Many of the medical breakthroughs from the last century could be lost because of the spread of antimicrobial resistance. Previously curable infectious diseases may become untreatable and risk spreading throughout the world.

 

In April 2015, WHO published a “Worldwide country situation analysis: Response to antimicrobial resistance.” It revealed that many governments are actively undertaking measures to address the problem, there are major gaps across all six WHO regions.

 

甘诺宝力

 

Continue reading to learn about the main causes of antimicrobial resistance (AMR) and how WHO is helping to lead the global response.

 

Fact 1: What is antimicrobial resistance?

Antimicrobial resistance is the ability of a micro-organism (like bacteria, viruses, and some parasites) to stop an antimicrobial (such as antibiotics, antivirals and antimalarials) from working against it. As a result, standard treatments become ineffective, infections persist and may spread to others.

 

 

Fact 2: Drug resistance is a global problem

Over the past years, the use and misuse of antimicrobials has increased the number and types of resistant organisms. Consequently many infectious diseases may one day become uncontrollable. With the growth of global trade and travel, resistant microorganisms can spread promptly to any part of the world.

 

甘诺宝力

 

Fact 3: What causes drug resistance?

Drug resistance is a natural evolutionary phenomenon. When microorganisms are exposed to an antimicrobial, the more susceptible organisms succumb, leaving behind those resistant to the antimicrobial. They can then pass on their resistance to their offspring.

 

Fact 4: Inappropriate use of medicines worsens drug resistance

Inappropriate use of antimicrobials drives the development of drug resistance. Overuse and misuse of medicines contribute to the problem. Ensuring that patients are informed about the need to take the right dosage of the right antimicrobial requires action from prescribers, pharmacists and dispensers, pharmaceutical industry, the public and patients, as well as the policy makers. 

 

Fact 5: New investment needed in the pipeline for new tools to combat drug resistance

Existing antibiotics and anti-parasitic drugs, and, to a lesser extent, antiviral drugs, are losing their effect. At the same time there is insufficient investment in developing new antimicrobials. Currently, there is insufficient new research into new diagnostics to detect resistant microorganisms; and new vaccines for preventing and controlling infections. If this trend continues, there won’t be any tools left to combat resistant microorganism.

 

安发国际

 

WHO calls on stakeholders to combat drug resistance

 

The threat from drug resistance is increasing. There is a need for urgent action; everyone must play a part. At the Sixty-eighth World Health Assembly in May 2015, Member States endorsed a global action plan to tackle antimicrobial resistance.

上一篇:国家药监局副局长孙梅君:制定翔实的排查计划

下一篇:生命不值钱!苏州五旬男连续加班4小时后猝死获赔20万

版权所有 中国直销资源网 http://www.cnzxzy.com
安发 一种可以根治各种慢性疾病的天然药物